|
| Status |
Public on Jun 01, 2022 |
| Title |
Melanoma GEMM Tumors, untreated or vemurafenib treated |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
30824837 |
| |
| Submission date |
Jun 01, 2022 |
| Last update date |
Sep 01, 2022 |
| Contact name |
Dorothee Nickles |
| E-mail(s) |
nicklesd@gene.com
|
| Organization name |
Genentech
|
| Street address |
1 DNA Way
|
| City |
South San Francisco |
| State/province |
CA |
| ZIP/Postal code |
94080 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
| GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
|
| Samples (37)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE126714 |
Melanoma GEMM Tumors, untreated or vemurafenib treated (scRNASeq) |
| GSE205251 |
Melanoma GEMM Tumors, untreated or vemurafenib treated [bulk RNA-seq] |
|
| Relations |
| BioProject |
PRJNA844332 |
Less...
More...